Abstract
2579 Background: TAS-102 is comprised of an antineoplastic thymidine-based nucleoside analog, trifluridine (FTD), and the thymidine phosphorylase inhibitor, tipiracil hydrochloride (TPI), at a mola...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have